Core Insights - Allergan Aesthetics, a subsidiary of AbbVie, is showcasing its leadership in the aesthetic industry by presenting 17 abstracts at the 2025 American Society of Dermatologic Surgery (ASDS) Annual Meeting, including three in the "Top Ten" session [1][2] - The presentations will cover Phase 3 clinical study results for trenibotulinumtoxinE, a first-in-class botulinum neurotoxin, and a Phase 4 study on BOTOX® Cosmetic, focusing on patient satisfaction and natural outcomes [1][3] - The company emphasizes its commitment to evidence-based innovation and improving patient care through its diverse product portfolio [2] Presentation Highlights - Key presentations include the efficacy and safety of trenibotulinumtoxinE for treating glabellar lines, and patient-reported satisfaction following BOTOX® Cosmetic treatment for upper facial lines [4][5] - An expert panel will discuss insights from the "Hyaluronic Acid Injectable Fillers Report," focusing on current usage and satisfaction data for hyaluronic acid fillers [4] - A symposium will address the latest indications for BOTOX® Cosmetic, including treatment for moderate to severe platysma bands [4] Educational Initiatives - Allergan Aesthetics will host educational programs aimed at understanding patient needs and enhancing clinical practices [3] - Presentations will also cover the benefits of long-term BOTOX® Cosmetic use and survey results on aesthetic concerns following medical weight loss [3][4] Company Overview - Allergan Aesthetics develops and markets a wide range of aesthetic products, including facial injectables and body contouring solutions, with a focus on innovation and customer service [30] - AbbVie aims to address serious health issues through innovative medicines, with a significant presence in the aesthetics market [31]

Core Viewpoint - Allergan Aesthetics, a subsidiary of AbbVie, has launched the HA5® Hydra Collagen Hydrating Foaming Cleanser, which is designed to provide hydration and thorough cleansing for the skin, enhancing the effectiveness of subsequent skincare products [1][2]. Product Overview - The HA5® Hydra Collagen Hydrating Foaming Cleanser features the proprietary HA5® Hydra Collagen Complex, which includes five forms of hyaluronic acid and vegan hydra collagen, aimed at delivering instant hydration [1][2]. - The cleanser is formulated with 100% naturally derived amino acid-based surfactants and Pea Peptides, making it suitable for dry and sensitive skin [2]. - Clinical studies indicate that the cleanser can effectively remove makeup and impurities while boosting skin hydration by 30% when used with the HA5® Hydra Collagen Replenish + Restore Hydrator [2][3]. Market Positioning - Allergan Aesthetics emphasizes innovation in aesthetic medicine, positioning the HA5® line as a benchmark for advanced skin hydration solutions [2]. - The new cleanser is part of a broader portfolio that includes products from SkinMedica®, SKINVIVE by JUVÉDERM®, and DiamondGlow®, all aimed at providing superior hydration [2]. Expert Endorsement - Dr. Tiffany J. Libby, a board-certified dermatologist, endorses the product, highlighting its dual function of cleansing and hydrating while respecting the skin barrier [3]. Pricing and Availability - The HA5® Hydra Collagen Hydrating Foaming Cleanser is priced at $48 and is available for purchase on SkinMedica.com [3].

SKINVIVE by JUVÉDERM® is currently approved in the U.S. as the first and only hyaluronic acid microdroplet injectable indicated to improve cheek skin smoothness. If approved, SKINVIVE by JUVÉDERM® will be the first hyaluronic acid injectable treatment option aiming to reduce neck lines. The application for indication expansion is supported by a clinical study that met all primary and secondary endpoints assessing SKINVIVE by JUVÉDERM® in adults with neck lines seeking improvement in neck appearance.1IRVIN ...